
Previous research has highlighted the fact that basic fibroblast growth factor exhibits a high affinity for heparin.
Heparin combined with basic fibroblast growth factor significantly contributes to the differentiation of umbilical cord mesenchymal stem cells into motor neurons.
Advertisement
Xueyuan Liu and colleagues from Liaoning Medical University found that the third passage of umbilical cord mesenchymal stem cells induced with heparin and basic fibroblast growth factor exhibited neuronal morphology, and Hb9 expression and acetylcholine levels increased following induction with heparin combined with basic fibroblast growth factor. These findings, published in the Neural Regeneration Research (Vol. 8, No. 22, 2013), indicate that heparin combined with basic fibroblast growth factor can noticeably promote the differentiation of umbilical cord mesenchymal stem cells into motor neuron-like cells. This technology is expected to prevent and treat muscular atrophy caused by peripheral nerve injury.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Genetics & Stem Cells News

Relapsing-remitting multiple sclerosis has been successfully treated using autologous hematopoietic stem cell therapy.

Innovative discoveries in male hair loss research uncover uncommon genetic variants tied to it.

Researchers achieved a significant milestone in uncovering the genetic basis of dilated cardiomyopathy in Dobermanns.

Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.

Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.